PROVEN is changing the wellness industry with AI & personalization

This offering is made in reliance on Regulation A under the Securities Act of 1933. The securities offered are speculative, illiquid, and an investor could lose the entire investment. Investors should read the relevant Offering Circular and consider the risks therein before investing. PROVEN is a startup and is operating at a loss and as a going concern.

As Seen In

Reasons to Invest

Don't miss your chance to become a shareholder in PROVEN.

Award-Winning Data

The power behind PROVEN is our award-winning Skin Genome Project™ database, which uses the wisdom of 4,000 scientific papers and 25 million consumer reviews to understand what works for customers.


From $0 to $10M to $20M per year in revenue in less than 2 years. Healthy unit economics and ability to acquire users efficiently; every customer acquired pays for themself in the first months.

Product Roadmap

Personalized skincare is just the beginning. Supplements, hair care, body care, cosmetics, and baby care products are all part of PROVEN’s plan to expand into multiple wellness categories.

Join the Discussion